BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6713735)

  • 1. Importance of central serotonin neurons in the hypotensive action of methyldopa in the rat.
    Choy VJ; Chalmers J
    Clin Exp Pharmacol Physiol; 1984; 11(1):37-44. PubMed ID: 6713735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulbospinal serotonin pressor pathways and hypotensive action of methyldopa in the rat.
    Chalmers JP; Minson JB; Choy V
    Hypertension; 1984; 6(5 Pt 2):II16-21. PubMed ID: 6500683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midline B3 serotonin nerves in rat medulla are involved in hypotensive effect of methyldopa.
    Macrae IM; Minson JB; Kapoor V; Morris MJ; Chalmers JP
    J Cardiovasc Pharmacol; 1986; 8(2):381-5. PubMed ID: 2422478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bulbospinal serotonin neurons and hypotensive effects of methyldopa in the spontaneously hypertensive rat.
    Minson JB; Choy VJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(2):312-7. PubMed ID: 6200721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyldopa hypotension and ascending projections from midline serotonin (B3) cells in the medulla.
    Chalmers JP; Macrae M; Minson JB; Kapoor V
    J Hypertens Suppl; 1985 Dec; 3(3):S111-2. PubMed ID: 2856683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the central hypotensive actions of alpha-methyldopa and clonidine in the spontaneously hypertensive rat: contribution of neurons arising from the B3 and the C1 areas of the rostral ventrolateral medulla.
    Drolet G; Aslanian V; Minson J; Morris M; Chalmers J
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):118-23. PubMed ID: 1688968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats.
    Freed CR; Wang CH; U'Prichard DC
    Hypertension; 1984; 6(5 Pt 2):II34-9. PubMed ID: 6094347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms.
    Abrams WB
    Hypertension; 1984; 6(5 Pt 2):II87-93. PubMed ID: 6150004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral autonomic mechanisms involved in the circulatory actions of methyldopa.
    Korner PI; Head GA; Bobik A; Badoer E; Aberdeen JA
    Hypertension; 1984; 6(5 Pt 2):II63-70. PubMed ID: 6437977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release.
    Wolf WA; Bobik A
    Eur J Pharmacol; 1989 Apr; 163(1):43-53. PubMed ID: 2472968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic serotonin receptors and alpha-adrenoceptors on central serotoninergic and noradrenergic neurons of normotensive and spontaneously hypertensive rats.
    Schlicker E; Classen K; Göthert M
    J Cardiovasc Pharmacol; 1988 May; 11(5):518-28. PubMed ID: 2455837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of noradrenaline and serotonin in the central control of blood pressure in normotensive and spontaneously hypertensive rats.
    de Jong W; Nijkamp FP; Bohus B
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):272-84. PubMed ID: 1147722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central serotonergic mechanisms in hypertension.
    Chalmers JP; Pilowsky PM; Minson JB; Kapoor V; Mills E; West MJ
    Am J Hypertens; 1988 Jan; 1(1):79-83. PubMed ID: 3285860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of methyldopa on brain cholinergic neurons involved in cardiovascular regulation. A study in conscious spontaneously hypertensive rats.
    Buccafusco JJ
    Hypertension; 1984; 6(5):614-21. PubMed ID: 6500669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to the study of bulbospinal (B3) serotonergic neurons in the control of blood pressure.
    Chalmers JP; Kapoor V; Macrae IM; Minson JB; Pilowsky P; West MJ
    J Hypertens Suppl; 1985 Dec; 3(4):S5-9. PubMed ID: 2870144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of brain acetylcholine biosynthesis by methyldopa in spontaneously hypertensive rats.
    Buccafusco JJ
    Brain Res Bull; 1984 Aug; 13(2):257-62. PubMed ID: 6498532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A centrally mediated peripheral hypotensive effect of alpha-methyldopa.
    Ingenito AJ; Barrett JP; Procita L
    J Pharmacol Exp Ther; 1970 Dec; 175(3):593-9. PubMed ID: 5489916
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha-methyldopa and brain monoamines].
    Niwa M; Kawano T; Fujita Y; Maemura S; Ozaki M
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):451-9. PubMed ID: 6813206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ; Conway E; Summers R; Beart P; Jarrott B
    Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.